NCT04671680

Brief Summary

The objective of this study is to investigate a technique to monitor blood pressure in women undergoing cesarean delivery with suspected placenta accreta spectrum. To achieve this objective, the investigators plan to conduct a prospective, observational study with the following aims: Specific Aim 1: Compare concordance between the systolic (SBP), diastolic (DBP), and mean arterial blood pressure (MAP) readings from the continuous non-invasive arterial blood pressure (CNAP) and IABP at several discrete points throughout the procedure Specific Aim 2: Determine the feasibility of using CNAP to aid in decision making by examining the parameters of volume responsiveness and arterial elastance at several discrete points throughout the procedure. The investigators hypothesize that the investigators can obtain similar blood pressure monitoring using CNAP as compared to the gold standard IABP in women undergoing cesarean delivery with suspected placenta accreta.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jan 2021

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 30, 2020

Completed
17 days until next milestone

First Posted

Study publicly available on registry

December 17, 2020

Completed
29 days until next milestone

Study Start

First participant enrolled

January 15, 2021

Completed
4.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2025

Completed
Last Updated

October 21, 2025

Status Verified

October 1, 2025

Enrollment Period

4.4 years

First QC Date

November 30, 2020

Last Update Submit

October 20, 2025

Conditions

Keywords

Placenta AccretaNon-Invasive Arterial Blood PressureInvasive Arterial Blood PressureHemorrhageHemorrhage, Postpartum

Outcome Measures

Primary Outcomes (1)

  • Comparing concordance between MAP from the CNAP and AIBP

    Comparing concordance of systolic blood pressure, mean arterial blood pressure, and diastolic blood pressure readings captured from the continuous non-invasive arterial blood pressure measurements and invasive arterial blood pressure measurements.

    MAP will be measured continuously throughout the operative case, with an average case timeframe of 4-6 hours.

Secondary Outcomes (6)

  • Additional Comparisons of SBP and DBP

    SBP and DBP will be measured continuously throughout the operative case, with an average case timeframe of 4-6 hours.

  • Stroke Volume

    Measured throughout the operative case, with an average case timeframe of 4-6 hours.

  • Systemic Vascular Resistance

    Measured throughout the operative case, with an average case timeframe of 4-6 hours.

  • Cardiac Output

    Measured throughout the operative case, with an average case timeframe of 4-6 hours.

  • Stroke Volume Variation

    Measured throughout the operative case, with an average case timeframe of 4-6 hours.

  • +1 more secondary outcomes

Study Arms (1)

Pregnant women with suspected placenta accreta

Pregnant women undergoing cesarean delivery with suspected placenta accreta spectrum.

Device: LiDCO CNAP Monitoring Equipment

Interventions

A continuous non-invasive arterial blood pressure monitor for rapidly changing hemodynamics.

Pregnant women with suspected placenta accreta

Eligibility Criteria

Age18 Years - 40 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsThis study will only enroll female patients given its focus on pregnancy-related complications
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Pregnant women undergoing cesarean delivery with suspected placenta accreta spectrum.

You may qualify if:

  • Women aged 18-40 years old with pregnancy complicated by accreta spectrum undergoing elective, scheduled cesarean delivery and possible hysterectomy

You may not qualify if:

  • Women aged \<18
  • Patients with cardiac arrhythmia
  • Vascular pathologies of the upper limbs (recent vascular surgery, Reynaud's disease, vascular stenosis)
  • Contraindication to neuraxial anesthesia
  • Emergent cases
  • Droplet or airborne precautions (as determined by BIDMC infection control policy)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Beth Israel Deaconess Medical Center

Boston, Massachusetts, 02215, United States

Location

Related Publications (13)

  • Hamilton BE, Martin JA, Osterman MJ, Curtin SC, Matthews TJ. Births: Final Data for 2014. Natl Vital Stat Rep. 2015 Dec;64(12):1-64.

    PMID: 26727629BACKGROUND
  • Creanga AA, Berg CJ, Syverson C, Seed K, Bruce FC, Callaghan WM. Pregnancy-related mortality in the United States, 2006-2010. Obstet Gynecol. 2015 Jan;125(1):5-12. doi: 10.1097/AOG.0000000000000564.

    PMID: 25560097BACKGROUND
  • Creanga AA, Berg CJ, Ko JY, Farr SL, Tong VT, Bruce FC, Callaghan WM. Maternal mortality and morbidity in the United States: where are we now? J Womens Health (Larchmt). 2014 Jan;23(1):3-9. doi: 10.1089/jwh.2013.4617.

    PMID: 24383493BACKGROUND
  • Chung E, Chen G, Alexander B, Cannesson M. Non-invasive continuous blood pressure monitoring: a review of current applications. Front Med. 2013 Mar;7(1):91-101. doi: 10.1007/s11684-013-0239-5. Epub 2013 Jan 23.

    PMID: 23345112BACKGROUND
  • Stenglova A, Benes J. Continuous Non-Invasive Arterial Pressure Assessment during Surgery to Improve Outcome. Front Med (Lausanne). 2017 Nov 17;4:202. doi: 10.3389/fmed.2017.00202. eCollection 2017.

    PMID: 29204425BACKGROUND
  • Maheshwari K, Khanna S, Bajracharya GR, Makarova N, Riter Q, Raza S, Cywinski JB, Argalious M, Kurz A, Sessler DI. A Randomized Trial of Continuous Noninvasive Blood Pressure Monitoring During Noncardiac Surgery. Anesth Analg. 2018 Aug;127(2):424-431. doi: 10.1213/ANE.0000000000003482.

    PMID: 29916861BACKGROUND
  • Bartels K, Esper SA, Thiele RH. Blood Pressure Monitoring for the Anesthesiologist: A Practical Review. Anesth Analg. 2016 Jun;122(6):1866-79. doi: 10.1213/ANE.0000000000001340.

    PMID: 27195632BACKGROUND
  • Rogge DE, Nicklas JY, Schon G, Grothe O, Haas SA, Reuter DA, Saugel B. Continuous Noninvasive Arterial Pressure Monitoring in Obese Patients During Bariatric Surgery: An Evaluation of the Vascular Unloading Technique (Clearsight system). Anesth Analg. 2019 Mar;128(3):477-483. doi: 10.1213/ANE.0000000000003943.

    PMID: 30649073BACKGROUND
  • Sumiyoshi M, Maeda T, Miyazaki E, Hotta N, Sato H, Hamaguchi E, Kanazawa H, Ohnishi Y, Kamei M. Accuracy of the ClearSight system in patients undergoing abdominal aortic aneurysm surgery. J Anesth. 2019 Jun;33(3):364-371. doi: 10.1007/s00540-019-02632-6. Epub 2019 Mar 23.

    PMID: 30904953BACKGROUND
  • Meidert AS, Nold JS, Hornung R, Paulus AC, Zwissler B, Czerner S. The impact of continuous non-invasive arterial blood pressure monitoring on blood pressure stability during general anaesthesia in orthopaedic patients: A randomised trial. Eur J Anaesthesiol. 2017 Nov;34(11):716-722. doi: 10.1097/EJA.0000000000000690.

    PMID: 28922340BACKGROUND
  • Cecconi M, Monge Garcia MI, Gracia Romero M, Mellinghoff J, Caliandro F, Grounds RM, Rhodes A. The use of pulse pressure variation and stroke volume variation in spontaneously breathing patients to assess dynamic arterial elastance and to predict arterial pressure response to fluid administration. Anesth Analg. 2015 Jan;120(1):76-84. doi: 10.1213/ANE.0000000000000442.

    PMID: 25230102BACKGROUND
  • Hohn A, Defosse JM, Becker S, Steffen C, Wappler F, Sakka SG. Non-invasive continuous arterial pressure monitoring with Nexfin does not sufficiently replace invasive measurements in critically ill patients. Br J Anaesth. 2013 Aug;111(2):178-84. doi: 10.1093/bja/aet023. Epub 2013 Mar 13.

    PMID: 23485882BACKGROUND
  • Gupta D, Soskin V, Marjanovic M, Amhaz H, Mazumdar A. CONTINUOUS NON-INVASIVE ARTERIAL PRESSURE DEVICE AS AN ADJUNCT TO RECOGNIZE FLUCTUATING BLOOD PRESSURES DURING ELECTIVE CESAREAN SECTION UNDER SUBARACHNOID BLOCKADE (SAB). Middle East J Anaesthesiol. 2016 Feb;23(4):385-400.

    PMID: 27382807BACKGROUND

MeSH Terms

Conditions

Placenta AccretaHemorrhagePostpartum Hemorrhage

Condition Hierarchy (Ancestors)

Obstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesPlacenta DiseasesPathologic ProcessesPathological Conditions, Signs and SymptomsPuerperal DisordersUterine Hemorrhage

Study Officials

  • John J. Kowalczyk, MD

    Beth Israel Deaconess Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor of Anaesthesia

Study Record Dates

First Submitted

November 30, 2020

First Posted

December 17, 2020

Study Start

January 15, 2021

Primary Completion

June 1, 2025

Study Completion

June 1, 2025

Last Updated

October 21, 2025

Record last verified: 2025-10

Data Sharing

IPD Sharing
Will not share

Locations